Explore how prognostic variables are revolutionizing leukemia treatment through personalized medicine approaches and advanced technologies.
Discover why some AML patients with monocytic differentiation don't respond to venetoclax+decitabine therapy and the emerging solutions to overcome this resistance.
Exploring the innovative combination of CPX-351 and Gemtuzumab Ozogamicin for treating relapsed/refractory AML and high-risk MDS
Exploring how nutrient media choice affects leukemic T-lymphoblasts in long-term cultures and its impact on cancer research accuracy.
Exploring the critical treatment decision between hematopoietic cell transplantation and chemotherapy for young adults with Acute Lymphoblastic Leukemia based on population-level analysis.
Exploring how Ras effector pathways differentially support proliferation and survival in Acute Myeloid Leukemia, revealing new therapeutic approaches.
Exploring the delicate balance of managing Chronic Myelogenous Leukemia treatment while pregnant, and the remarkable fetal-maternal cellular connection.